Dongcheng Pharmaceutical's Controlling Shareholder Pledges 19.41 Million Shares, Cumulative Pledge Exceeds 30% of Holdings

Corporate Action
โดย 财中社·Read original
Summary · why it matters

Dongcheng Pharmaceutical's controlling shareholder, Dongyi Biotech, has pledged 19.41 million shares, representing 15.54% of its holdings and 2.35% of the company's total share capital. As of the announcement date, Dongyi Biotech's cumulative pledged shares amount to 41.41 million, accounting for 33.16% of its holdings and 5.02% of the company's total share capital. In the first quarter of 2026, Dongcheng Pharmaceutical achieved revenue of 626 million yuan and a net profit attributable to the parent company of 33.44 million yuan.

Impact on stocks 1

Others▼ · 1 stocks
Yantai Dongcheng Pharmaceutical Co Ltd
002675
▼ NegativeCapitalrelevance

Controlling shareholder pledges additional shares, with cumulative pledge exceeding 30% of holdings, signaling potential financial strain or risk of forced selling.

Off-coverage companies 1

东益生物Private▼ Negative
Capitalrelevance

As the controlling shareholder, Dongyi Biotech's increased pledge activity may indicate liquidity pressure or financing needs, negatively affecting its financial stability.

© 2026 MarketDXNews